BioSpace Global Roundup: Shanghai Ecosystem Grows with Addition of Germany's ITM AG
Published: May 12, 2021 By Alex Keown Shanghai continues to be an area of focus for many pharmaceutical companies seeking a toehold in China. Companies like AstraZeneca, Novartis and others have opened offices in Shanghai. Two months ago, Germany’s Vetter, a contract development and manufacturing organization, opened offices there, and now, ITM AG, another Germany-based company is following suit. ITM AG established a subsidiary in Shanghai to accelerate introduction of its precision oncology portfolio in China. The subsidiary will expand ITM’s growing operations in China, which is...
Source: biospace.com